About Adlai Nortye Ltd
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: KY
- Website: https://www.adlainortye.com/
Frequently Asked Questions
What is the 52-week range for ANL?
The 52-week high is $17.25 and the 52-week low is $0.879.
What is the P/E ratio for ANL?
The P/E ratio data is currently unavailable.
What is the dividend yield for ANL?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -2.48%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.89.
Analyst Recommendation Trends
Wall Street analyst consensus for ANL over the last few months:
Latest ANL News
Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations
SINGAPORE and NORTH BRUNSWICK, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Group Ltd. (NASDAQ: ANL) (“Adlai Nortye” or the “Company”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced the appointment of Christopher Liu, PharmD, as Head of Investor Relations and Public Relations. Dr. Liu brings nearly a decade of equity research experience, with a focus on biotechnology and oncology. “We are pleased to welcome Chris to Adl
4.8x P B? Adlai Nortye Group (ANL) On Its AN4035 Trial Progress
Why the AN4035 trial move matters for Adlai Nortye Group stock Adlai Nortye Group (NasdaqGM:ANL) has just dosed the first patient in its global Phase I trial for AN4035 and secured a Study May Proceed letter from the FDA, clearing expansion into the United States. The fresh AN4035 milestone comes after a strong run in Adlai Nortye Group’s stock, with a very large year-to-date share price return and a 1-year total shareholder return of about 8x. Recent 30-day and 90-day share price returns of...
Jefferies Initiates Coverage On Adlai Nortye with Buy Rating, Announces Price Target of $31
Jefferies analyst Maury Raycroft initiates coverage on Adlai Nortye (NASDAQ:ANL) with a Buy rating and announces Price Target of $31.
HC Wainwright & Co. Reiterates Buy on Adlai Nortye, Maintains $20 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Adlai Nortye (NASDAQ:ANL) with a Buy and maintains $20 price target.
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
First-in-class CEACAM5-targeting ADC armed with a pan-RAS(ON) inhibitor – designed for tumor-selective RAS pathway inhibition First patient dosed in Australia; global Phase I initiated U.S. FDA cleared IND with "Study-May-Proceed" letter SINGAPORE and NORTH BRUNSWICK, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Group Ltd. (NASDAQ: ANL) (“Adlai Nortye” or the “Company”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced tha
These 2 ‘Monster Growth’ Stocks Aren’t Done Climbing, Say Analysts
Ask any old-school market investor and he’ll tell you that the cliché is true, and ‘past performance cannot guarantee future returns.’ If that were true without exception, then growth investing would not be a viable option – but we all know that investors love to buy into stocks that have shown enormous growth in recent months. The ‘monster growth’ stocks are popular because investing into them is successful. The key is understanding the smart middle way, and treating stocks as individuals, with
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-30 | Ji Ping | -5,000 | $15.95 | $79,750 |
| 2026-09-30 | Ji Ping | -5,000 | $16.03 | $80,150 |
| 2026-09-29 | Ji Ping | -214 | $15.77 | $3,375 |
| 2026-09-22 | Ji Ping | -5,000 | $16.63 | $83,150 |
| 2026-08-26 | Ye Xiaofeng | -5,667 | $14.25 | $80,755 |
| 2026-08-24 | Ye Xiaofeng | -6,000 | $13.98 | $83,880 |
| 2026-06-10 | Ji Ping | +136,667 | - | - |
| 2026-05-13 | LU YANG | -10 | $13.18 | $132 |